1. Patient-reported Outcomes as a Source of Evidence in Off-Label Prescribing: Analysis of Data From Jeana Frost, Sally Okun, Timothy Vaughan, James Heywood, and Paul WicksPresenter:…

Slide 1Impact of Exploratory Analysis on Drug Approval Joga Gobburu Pharmacometrics Office Clinical Pharmacology, CDER, FDA [email protected] Slide 2 2 Take Home…

1. Realizing the Power of Real TimeInformation forDrug Development and New Product Launch2nd International Conference on MarketResearch in the Mobile [email protected]…

DEVELOPMENT AND VALIDATION OF ZIDOVUDINE BY RP-HPLC METHOD Guided by Prof. T. Satyanarayana D. Narendra Principal Vice principal Lydia college of pharmacy BY U. Aparna Rajeevi…

Slide 1Cryosurgery and Electrosurgery Adam O. Goldstein, MD Associate Professor UNC Dept Family Medicine Chapel Hill, NC [email protected] Slide 2 Objectives l Know indications…

WHAT IS A BIOSTATISTICIAN TRYING TO PROVE? WHAT IS A BIOSTATISTICIAN TRYING TO PROVE? PROOF IN MEDICAL RESEARCH Susan S. Ellenberg, Ph.D. Department of Biostatistics and…

* Who Needs Bayesian Phase I Trials? Rick Chappell Professor, Departments of Statistics and of Biostatistics and Medical Informatics University of Wisconsin Madison [email protected]…

Leukemia treatment on the fast track At the vanguard of stem cell research A new drug for Alzheimerâs Leukemia meets its match. In this edition of The Burnham Report, youâll…

Alzheimer’s disease (AD) — the most common form of irreversible dementia — is placing a considerable and increasing burden on patients, caregivers and society, as more…

WHAT IS A BIOSTATISTICIAN TRYING TO PROVE? WHAT IS A BIOSTATISTICIAN TRYING TO PROVE? PROOF IN MEDICAL RESEARCH Susan S. Ellenberg, Ph.D. Department of Biostatistics and…